NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
Clinical Trials
17 trialsNCT07462663 2026-03-10
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT05316467 2025-08-11
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Fudan University
Phase 2/3 Recruiting
NCT05247268 2025-04-06
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Fudan University
Phase 2 Recruiting
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT06549855 2024-08-12
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Peking University People's Hospital
Phase NA Not yet recruiting
NCT06417736 2024-05-16
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05332483 2023-11-03
MA-EEC
Sunnybrook Health Sciences Centre
Phase 1 Terminated
NCT03077698 2022-06-07
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Xenetic Biosciences, Inc.
Phase 2 Terminated
NCT00729586 2019-07-23
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00910091 2019-01-30
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Ipsen
Phase 2 Completed
NCT00483327 2018-04-04
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
NYU Langone Health
Phase 2 Completed
NCT00739830 2015-07-01
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01943058 2014-09-10
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
University of Southern California
Phase 2 Withdrawn
NCT00002465 2013-11-06
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00016341 2013-04-11
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
GOG Foundation
Phase 3 Terminated